WHO Drug Information - Volume 39, No. 4
30 January 2026
| Publication
Overview
The Fourth issue of volume 39 for 2025 includes:
Pharmaceutical News
- Thin-Layer Chromatography: A Valuable Tool in the Fight Against Substandard/Falsified Medicines
Consultation Documents
- Tenofovir Alafenamide Hemifumarate (tenofoviri alafenamidi hemifumaras)
- Diethylcarbamazine Tablets (diethylcarbamazini compressi)
- Cefiderocol Powder for Concentrate for Solution for Infusion (cefiderocoli pulvis pro concentrato pro solutione pro infusione)
- Cefiderocol Sulfate Tosilate (cefiderocoli sulfas tosilatum)
Anatomical Therapeutic Chemical/Defined Daily Dose (ATC/DDD) Classification
- ATC/DDD Classification (Temporary)
- ATC/DDD Classification (Final)
Volume 39, issue 4 concludes with the International Nonproprietary Names (INN) List - Proposed INN List No. 134
WHO Team
Access to Medicines and Health Products (MHP),
Health Product Policy and Standards (HPS),
INN and Classification of Medical Products (INN),
Prequalification (PQT),
Regulation and Prequalification (RPQ),
Regulation and safety (REG)
Editors
World Health Organization
Number of pages
366
Reference numbers
ISBN: 978-92-4-012052-5
Copyright
